Latest Regulatory News

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Catalina Resources is set to launch a significant Phase 1 drilling campaign across its Evanston and Yerilgee gold projects starting December 1, 2025, aiming to deepen understanding of promising mineralised zones.

Corazon Mining has formalised a key land access agreement with the Marputu Aboriginal Corporation, securing tenure and advancing exploration plans at its Two Pools Gold Project in Western Australia.

Bubalus Resources reports significant high-grade gallium, manganese, and cobalt assays from its Amadeus Project, while preparations for maiden drilling at Nolan’s East advance with key approvals secured.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Forrestania Resources Limited has initiated an all-scrip off-market takeover offer for Kula Gold Limited, aiming to consolidate gold exploration assets across Western Australia. The offer, valued up to $58.7 million, comes with unanimous backing from Kula's board.

A former director of Emu NL has lodged a formal application with the Takeovers Panel, contesting the legitimacy of a recent $1.4 million institutional placement and alleging undisclosed attempts to influence board control.

Great Divide Mining Ltd has agreed to acquire the remaining 49% stake in Challenger Mines Pty Ltd from Adelong Gold Limited, aiming to resolve a protracted joint venture dispute and restart operations at the Challenger Gold Mine.

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Sequoia Financial Group has acknowledged that ASIC’s civil penalty proceedings against its subsidiary InterPrac are material and confirmed timely disclosure to the market following formal notification.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.